Apellis Pharmaceuticals IncのSMA 200

Apellis Pharmaceuticals IncのSMA 200は何ですか。

Apellis Pharmaceuticals IncのSMA 200は$46 -20.34%です。

SMA 200の定義は何ですか。



SMA 200は、過去200日間の終値の非加重平均として計算された過去200日間の平均株価です。

Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.

Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.

NASDAQのセクタHealth CareにおけるSMA 200の企業と比べるApellis Pharmaceuticals Inc

Apellis Pharmaceuticals Incは何をしますか。

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Apellis Pharmaceuticals Incと類似のsma 200